Your search returned 6 results.

Results
	1.	Heparin dosing for percutaneous coronary angioplasty: use of body surface area to improve initial activated clotting time values. [electronic resource] by Pesola, G R Pesola, D A Producer: 19980203 In: Clinical cardiology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Percutaneous transluminal coronary angioplasty: comparison of arterial vs. venous activated clotting time. [electronic resource] by Pesola, G R Johnson, A Pesola, D A Producer: 19961204 In: Catheterization and cardiovascular diagnosis vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Blood pressure reduction and stroke. [electronic resource] by Pesola, G R Avasarala, J Pesola, D A Producer: 20011204 In: The Journal of emergency medicine vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A stabilization period of 5 minutes is adequate when measuring pulmonary artery pressures after turning. [electronic resource] by Pesola, H R Pesola, D A Pesola, G R Producer: 19941101 In: American journal of critical care : an official publication, American Association of Critical-Care Nurses vol. 3 Availability: No items available. Save to lists Add to cart (remove)
	5.	Advantages for the use of the activated clotting time (ACT) [electronic resource] by Pesola, D A Pesola, H R Pesola, G R Producer: 19960104 In: American journal of critical care : an official publication, American Association of Critical-Care Nurses vol. 4 Availability: No items available. Save to lists Add to cart (remove)
	6.	Cardiac biomarkers. [electronic resource] by Pesola, G R Pesola, H R Pesola, D A Producer: 19990610 In: American journal of critical care : an official publication, American Association of Critical-Care Nurses vol. 8 Availability: No items available. Save to lists Add to cart (remove)